BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26109911)

  • 1. Chicken chorioallantoic membrane as a reliable model to evaluate osteosarcoma-an experimental approach using SaOS2 cell line.
    Manjunathan R; Ragunathan M
    Biol Proced Online; 2015; 17():10. PubMed ID: 26109911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of the chicken chorioallantoic membrane assay as reliable in vivo model for the analysis of osteosarcoma.
    Kunz P; Schenker A; Sähr H; Lehner B; Fellenberg J
    PLoS One; 2019; 14(4):e0215312. PubMed ID: 30986223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane.
    Balke M; Neumann A; Kersting C; Agelopoulos K; Gebert C; Gosheger G; Buerger H; Hagedorn M
    BMC Res Notes; 2010 Mar; 3():58. PubMed ID: 20202196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
    Özcetin A; Aigner A; Bakowsky U
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In ovo administration of human recombinant leptin shows dose dependent angiogenic effect on chicken chorioallantoic membrane.
    Manjunathan R; Ragunathan M
    Biol Res; 2015 Jun; 48(1):29. PubMed ID: 26060038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells.
    Mangieri D; Nico B; Coluccia AM; Vacca A; Ponzoni M; Ribatti D
    Cancer Lett; 2009 May; 277(2):199-204. PubMed ID: 19150583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of pro-angiogenic molecules and events does not relate with an angiogenic switch in metastatic osteosarcoma cells but to cell survival features.
    Gutiérrez LM; Valenzuela Alvarez M; Yang Y; Spinelli F; Cantero MJ; Alaniz L; García MG; Kleinerman ES; Correa A; Bolontrade MF
    Apoptosis; 2021 Aug; 26(7-8):447-459. PubMed ID: 34024019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumorigenesis and spontaneous metastasis by luciferase-labeled human xenograft osteosarcoma cells in nude mice.
    Du L; Xu WT; Fan QM; Tu B; Shen Y; Yan W; Tang TT; Wang Y
    Chin Med J (Engl); 2012 Nov; 125(22):4022-30. PubMed ID: 23158137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDC-0152 attenuates the malignant progression of osteosarcoma promoted by ANGPTL2 via PI3K/AKT but not p38MAPK signaling pathway.
    Yang L; Shu T; Liang Y; Gu W; Wang C; Song X; Fan C; Wang W
    Int J Oncol; 2015 Apr; 46(4):1651-8. PubMed ID: 25651778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental tumor growth of canine osteosarcoma cell line on chick embryo chorioallantoic membrane (in vivo studies).
    Walewska M; Dolka I; Małek A; Wojtalewicz A; Wojtkowska A; Żbikowski A; Lechowski R; Zabielska-Koczywąs K
    Acta Vet Scand; 2017 May; 59(1):30. PubMed ID: 28499392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents.
    Tufan AC; Satiroglu-Tufan NL
    Curr Cancer Drug Targets; 2005 Jun; 5(4):249-66. PubMed ID: 15975046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin regulates tumor angiogenesis via miR-424-5p/VEGFA signaling pathway in osteosarcoma.
    Vimalraj S; Saravanan S; Raghunandhakumar S; Anuradha D
    Life Sci; 2020 Sep; 256():118011. PubMed ID: 32592723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of collateral vessels: A new paradigm in CAM angiogenesis model.
    Gatne DP; Mungekar S; Addepalli V; Mohanraj K; Ghone SA; Rege NN
    Microvasc Res; 2016 Jan; 103():11-3. PubMed ID: 26390964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of patient-derived xenografts of retinoblastoma and choroidal melanoma on the avian chorioallantoic membrane.
    Kant N; Jayaraj P; Sen S; Rupani H; Kumar P; Dahiya S; Chugh P; Gupta M; Sengar M
    Indian J Ophthalmol; 2023 Mar; 71(3):977-982. PubMed ID: 36872721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein and activin membrane-bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF-β-induced EMT signaling pathway.
    Liu F; Wang K; Zhang L; Yang YL
    Oncol Lett; 2018 Oct; 16(4):5113-5121. PubMed ID: 30250579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis.
    Roomi MW; Roomi N; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Oncol Rep; 2005 Oct; 14(4):807-15. PubMed ID: 16142336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SaOS2 Osteosarcoma cells as an in vitro model for studying the transition of human osteoblasts to osteocytes.
    Prideaux M; Wijenayaka AR; Kumarasinghe DD; Ormsby RT; Evdokiou A; Findlay DM; Atkins GJ
    Calcif Tissue Int; 2014 Aug; 95(2):183-93. PubMed ID: 24916279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assay.
    Chen H; Wang CS; Li M; Sanchez E; Li J; Berenson A; Wirtschafter E; Wang J; Shen J; Li Z; Bonavida B; Berenson JR
    Int J Oncol; 2010 Jul; 37(1):71-9. PubMed ID: 20514398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of TNF-alpha on human osteosarcoma cell line Saos2--TNF-alpha regulation of bone sialoprotein gene expression in Saos2 osteoblast-like cells.
    Nakayama Y; Kato N; Nakajima Y; Shimizu E; Ogata Y
    Cell Biol Int; 2004; 28(10):653-60. PubMed ID: 15516323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying the chicken embryo chorioallantoic membrane assay to study treatment approaches in urothelial carcinoma.
    Skowron MA; Sathe A; Romano A; Hoffmann MJ; Schulz WA; van Koeveringe GA; Albers P; Nawroth R; Niegisch G
    Urol Oncol; 2017 Sep; 35(9):544.e11-544.e23. PubMed ID: 28551413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.